Your browser doesn't support javascript.
loading
Exceptional Responses to Selpercatinib in RET Fusion-Driven Metastatic Pancreatic Cancer.
Bhamidipati, Deepak; Yedururi, Sireesha; Huse, Jason; Chinapuvvula, Sri Veda; Wu, Jie; Subbiah, Vivek.
Afiliación
  • Bhamidipati D; Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX.
  • Yedururi S; Department of Radiology, The University of Texas MD Anderson Cancer Center, Houston, TX.
  • Huse J; Department of Pathology and Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX.
  • Chinapuvvula SV; Medical Science Academy, Hightower High School, Houston, TX.
  • Wu J; Peggy and Charles Stephenson Cancer Center and the Department of Pathology, The University of Oklahoma Health Science Center, Oklahoma City, OK.
  • Subbiah V; Department of Investigational Cancer Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, TX.
JCO Precis Oncol ; 7: e2300252, 2023 Sep.
Article en En | MEDLINE | ID: mdl-38039431
Asunto(s)
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias Pancreáticas / Pirazoles Límite: Humans Idioma: En Revista: JCO Precis Oncol Año: 2023 Tipo del documento: Article Pais de publicación: Estados Unidos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias Pancreáticas / Pirazoles Límite: Humans Idioma: En Revista: JCO Precis Oncol Año: 2023 Tipo del documento: Article Pais de publicación: Estados Unidos